On November 27, 2016, investigators gathered for the formal closeout of our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. Conducted by Clinical Trial Leader Alli Feduccia, Ph.D., the closeout included a thorough review of the study’s documentation, database, files, and adherence to regulations. All treatment sessions and long-term follow-up interviews for this study have now been completed. Led by Principal Investigator Ingrid Pacey, M.D., this small pilot study gave Canadian therapists experience delivering MDMA-assisted psychotherapy for PTSD, with data collected from three women and three men. The final results are being prepared for publication as a part of a global meta-analysis of MDMA-assisted psychotherapy results. Learn more…
